Direxion Daily S&P Biotech Bear 3X ETF
LABD
12 hedge funds and large institutions have $28.8M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.
65% more call options, than puts
Call options by funds: $41.2M | Put options by funds: $24.9M
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
8.42% more ownership
Funds ownership: 34.75% → 43.17% (+8.4%)
7% less capital invested
Capital invested by funds: $30.9M → $28.8M (-$2.08M)
33% less funds holding
Funds holding: 18 → 12 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.76M |
| 2 |
Jane Street
New York
|
+$3.76M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.12M |
| 4 |
IMC Chicago
Chicago,
Illinois
|
+$1.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$569K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$6.45M |
| 2 |
HF
HRT Financial
New York
|
-$1.44M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.35M |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$491K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$132K |
LABD Hedge Fund Activity: Q3 2020 in Review
12 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2020, worth a combined $28.8M — down 6.7% from $30.9M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LABD and 2 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Susquehanna International Group, adding an estimated $3.76M. The largest seller was Boxer Capital, cutting an estimated $6.45M.
- 12 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2020, down from 18 in Q2 2020.
- Funds reported $28.8M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2020, down 6.7% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2020 and 8 closed out, a net change of -6 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2020 was Susquehanna International Group, an estimated $3.76M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2020 was Boxer Capital, an estimated $6.45M sold.
Based on aggregated 13F filings for Q3 2020.